- "No observable adverse effects"... TICK
- "Drug distribution to cyst-forming cells"... BIG TICK (from memory in the last presentation Rohan mentioned this was a key thing big pharma were looking for).
Impressive how well this team keep delivering. Let's hope that progresses all the way to the patients and helps change the lives of many.
Ann: PYC to Progress Kidney Drug Candidate Into Human Trials, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.20 |
Change
0.040(3.45%) |
Mkt cap ! $699.9M | |||
| Open | High | Low | Value | Volume |
| $1.19 | $1.20 | $1.18 | $97.44K | 81.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 19651 | 3 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |